Formulate

Find pharma jobs. Prep for interviews like no one else can.

Browse

Jobs Companies Drugs Indications Career Advisor About

Insider Intel

Intelligence Hub Therapeutic Areas Contribute Intro Network Salary Explorer For Employers Pricing

Legal

Commercial Jobs in Biotech & Pharma | Formulate

All Jobs

Commercial Jobs

8,498 open commercial positions

Research & Development Clinical Development Clinical Operations Regulatory Affairs Quality Assurance Manufacturing Medical Affairs Business Development

Hospital Sales Specialist – Contrast Media & Radiopharmaceuticals

GE HealthCare

Posted 2mo ago

Carnaxide

Full-time

CommercialCardiology

MID

Sales Leader, Strategic Key Accounts

Philips

Posted 2mo ago

Istanbul

Full-time

CommercialOphthalmologyMID

Sales Associate - Houston, TX - Sports Medicine

Stryker

Posted 2mo ago

Houston, Texas

Full-time

CommercialNeurologyEntry

H-1B · 3 FY23

Sr Account Manager, Infusion Delivery Solutions - West

Fresenius Kabi

Posted 2mo ago

Colorado; Utah; Washington; Oregon

$90K - $110K

Full-time

CommercialSenior

H-1B · 2 FY23

Territory Sales Manager, Trauma

Stryker

Posted 2mo ago

Oslo, Norway

Full-time

CommercialNeurologyMANAGER

H-1B · 3 FY23

Territory Sales Manager - Northern Italy

Haemonetics

Posted 2mo ago

Remote

Full-time

RemoteCommercialGastroenterologyMANAGER

H-1B · 1 FY23

Sr. Insights & Analytics Manager (18-month contract)

GSK

Posted 2mo ago

Canada - Ontario - Mississauga; Canada – Ontario – GTA; Canada – Ontario – Kitchener/Waterloo; Canada – Quebec – Montréal; Montreal Queen Street; Canada – Ontario – Hamilton; Canada – Ontario – Oakville (Hybrid (Remote & On-site))

Full-time

CommercialInfectious DiseaseSenior

H-1B · 1 FY23

Thought Leader Liaison - TAVNEOS - Great Lakes (Rare Disease)

Amgen

Posted 2mo ago

Ohio - Cleveland; US - Illinois - Chicago; US - Kentucky - Louisville; US - West Virginia - Charleston; US - Wisconsin - Milwaukee; US - Michigan - Detroit, US (Field Worker)

Full-time

Related drug: TAVNEOS

CommercialRare DiseaseMID

H-1B · 3 FY23